微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 28.05% | -14.51% | 1.3% | 37/52 | 36.42% | 诺泰生物 | 69.32% | 行业排名> |
| 2024-06-30 | 27.69% | -16.46% | 8.48% | 38/52 | 36.51% | 百诚医药 | 68.75% | 行业排名> |
| 2024-03-31 | 25.53% | -23.86% | -18.4% | 38/52 | 36.38% | 百诚医药 | 68.19% | 行业排名> |
| 2023-12-31 | 31.29% | -15.8% | -4.66% | 37/52 | 38.59% | 药康生物 | 67.61% | 行业排名> |
| 2023-09-30 | 32.81% | -20.21% | -1.01% | 38/52 | 40.29% | 药康生物 | 69.14% | 行业排名> |
| 2023-06-30 | 33.15% | -23.3% | -1.13% | 39/52 | 40.13% | 药康生物 | 68.49% | 行业排名> |
| 2023-03-31 | 33.53% | -23.71% | -9.77% | 39/52 | 39.27% | 药康生物 | 69.3% | 行业排名> |
| 2022-12-31 | 37.16% | -2.88% | -9.65% | 36/52 | 40.44% | 药康生物 | 71.38% | 行业排名> |
| 2022-09-30 | 41.13% | 6.56% | -4.85% | 29/52 | 41.37% | 药康生物 | 73.27% | 行业排名> |
| 2022-06-30 | 43.22% | 18.58% | -1.66% | 24/52 | 40.21% | 药康生物 | 75.32% | 行业排名> |
| 2022-03-31 | 43.95% | 15.6% | 14.86% | 23/52 | 38.93% | 药康生物 | 76.7% | 行业排名> |
| 2021-12-31 | 38.26% | 0.1% | -0.86% | 37/52 | 42.21% | 药康生物 | 74.33% | 行业排名> |
| 2021-09-30 | 38.59% | 3.12% | 5.89% | 27/52 | 43.4% | 南华生物 | 84.53% | 行业排名> |
| 2021-06-30 | 36.45% | -1.4% | -4.13% | 35/52 | 42.88% | 南华生物 | 83.19% | 行业排名> |
| 2021-03-31 | 38.02% | 31.17% | -0.54% | 21/52 | 40.06% | 南华生物 | 83.9% | 行业排名> |
| 2020-12-31 | 38.22% | 18.89% | 2.13% | 35/52 | 38.9% | 成都先导 | 79.36% | 行业排名> |
| 2020-09-30 | 37.43% | 15.93% | 1.24% | 23/52 | 37.76% | 成都先导 | 75.92% | 行业排名> |
| 2020-06-30 | 36.97% | 12.29% | 27.54% | 26/52 | 39.73% | 南华生物 | 78.74% | 行业排名> |
| 2020-03-31 | 28.98% | -6.56% | -9.85% | 21/52 | 33.2% | 成都先导 | 80.82% | 行业排名> |
| 2019-12-31 | 32.15% | -5.56% | -0.41% | 43/52 | 43.15% | 成都先导 | 81.55% | 行业排名> |
| 2019-09-30 | 32.28% | -3.85% | -1.94% | 26/52 | 44.93% | 海特生物 | 84.37% | 行业排名> |
| 2019-06-30 | 32.92% | -1.91% | 6.14% | 28/52 | 45.53% | 海特生物 | 87.74% | 行业排名> |
| 2019-03-31 | 31.02% | -3.68% | -8.89% | 26/52 | 43.89% | 海特生物 | 88.04% | 行业排名> |
| 2018-12-31 | 34.04% | 1.89% | 1.39% | 37/52 | 42.47% | 海特生物 | 92.52% | 行业排名> |
| 2018-09-30 | 33.58% | -0.8% | 0.04% | 23/52 | 44.34% | 海特生物 | 94.18% | 行业排名> |
| 2018-06-30 | 33.56% | -0.22% | 4.23% | 27/52 | 44.61% | 海特生物 | 94.39% | 行业排名> |
| 2018-03-31 | 32.2% | 0.76% | -3.62% | 24/52 | 46.34% | 海特生物 | 94.57% | 行业排名> |
| 2017-12-31 | 33.41% | 6.09% | -1.29% | 32/52 | 41.42% | 退市海医 | 87.54% | 行业排名> |
| 2017-09-30 | 33.85% | 7.54% | 0.62% | 20/52 | 44.64% | 海特生物 | 95.31% | 行业排名> |
| 2017-06-30 | 33.64% | 5.66% | 5.25% | 23/52 | 43.99% | 退市海医 | 91.85% | 行业排名> |
| 2017-03-31 | 31.96% | 9.27% | 1.47% | 16/52 | 38.7% | 海特生物 | 95.45% | 行业排名> |
| 2016-12-31 | 31.49% | -6.32% | 0.06% | 26/52 | 40.69% | 退市海医 | 96.32% | 行业排名> |
| 2016-09-30 | 31.47% | -10.25% | -1.14% | 16/52 | 37.08% | 海特生物 | 95.35% | 行业排名> |
| 2016-06-30 | 31.84% | -12.66% | 8.85% | 16/52 | 32.79% | 退市海医 | 95.27% | 行业排名> |
| 2016-03-31 | 29.25% | -14.12% | -13.01% | 12/52 | 28.42% | 盈康生命 | 75.69% | 行业排名> |
| 2015-12-31 | 33.62% | -7.89% | -4.14% | 18/52 | 37.17% | 海特生物 | 95.38% | 行业排名> |
| 2015-09-30 | 35.07% | -4.12% | -3.78% | 11/52 | 33.25% | 药石科技 | 67.7% | 行业排名> |
| 2015-06-30 | 36.45% | -3.01% | 7.03% | 10/52 | 32.07% | 药石科技 | 66.33% | 行业排名> |
| 2015-03-31 | 34.05% | -4.9% | -6.7% | 9/52 | 24.2% | 睿智医药 | 52.68% | 行业排名> |
| 2014-12-31 | 36.5% | -1.64% | -0.21% | 16/52 | 35.91% | 海特生物 | 95.14% | 行业排名> |
| 2014-09-30 | 36.58% | -1.8% | -2.67% | 11/52 | 31.52% | 皓宸医疗 | 52.16% | 行业排名> |
| 2014-06-30 | 37.58% | -1.39% | 4.95% | 9/52 | 30.64% | 皓宸医疗 | 55.65% | 行业排名> |
| 2014-03-31 | 35.81% | 0.82% | -3.51% | 9/52 | 31.6% | 新里程 | 53.57% | 行业排名> |